← Back to Clinical Trials
Recruiting NCT07316179

NCT07316179 Predicting Difficult Intubation in Bariatric Surgery: Comparison of El Ganzouri Risk Index and Airway Ultrasound

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07316179
Status Recruiting
Phase
Sponsor Antalya Training and Research Hospital
Condition Obesity & Overweight
Study Type OBSERVATIONAL
Enrollment 52 participants
Start Date 2025-12-25
Primary Completion 2026-06

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 52 participants in total. It began in 2025-12-25 with a primary completion date of 2026-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is designed as a prospective observational study and will be conducted at the Health Sciences University Antalya Training and Research Hospital. Adult patients scheduled to undergo bariatric surgery will be included. The aim of this study is to compare the El Ganzouri Risk Index (EGRI) and airway ultrasonography (USG) parameters in predicting difficult intubation and to evaluate their relationship with the Cormack-Lehane (CL) score obtained during direct laryngoscopy. Before surgery, each participant will be evaluated using both the EGRI scoring system and airway USG. During general anesthesia, tracheal intubation will be performed using direct laryngoscopy, and data including the CL score, intubation time, number of attempts, and the need for videolaryngoscopy will be recorded based on the anesthesiologist's observations. The collected data will be analyzed by classifying participants according to the presence or absence of difficult intubation, and statistical comparisons will be performed between EGRI scores and airway ultrasonography parameters. The results of this study may contribute to improved preoperative airway assessment and enhanced patient safety in bariatric surgery.

Eligibility Criteria

Inclusion Criteria: * Adult patients aged 18 to 65 years. * ASA physical status classification II or III. * Scheduled to undergo elective bariatric surgery under general anesthesia. * Patients who voluntarily agree to participate in the study and sign the informed consent form. Exclusion Criteria: * Patients younger than 18 years or older than 65 years * Presence of upper airway anatomical pathology * History of tracheal or thyroid surgery. * History of radiotherapy to the head and neck region. * Cervical spine anomalies. Individuals unwilling to participate in the study.

Contact & Investigator

Central Contact

Ece Ilayda Tekdemir

✉ ilaydatekdemir@hotmail.com

📞 +905362905627

Principal Investigator

Mehmet Tercan

STUDY DIRECTOR

University of Health Sciences Antalya Training and Research Hospital

Frequently Asked Questions

Who can join the NCT07316179 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Obesity & Overweight. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07316179 currently recruiting?

Yes, NCT07316179 is actively recruiting participants. Contact the research team at ilaydatekdemir@hotmail.com for enrollment information.

Where is the NCT07316179 trial being conducted?

This trial is being conducted at Antalya, Turkey (Türkiye).

Who is sponsoring the NCT07316179 clinical trial?

NCT07316179 is sponsored by Antalya Training and Research Hospital. The principal investigator is Mehmet Tercan at University of Health Sciences Antalya Training and Research Hospital. The trial plans to enroll 52 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology